Inhibitory effect of amylin on basal and parathyroid hormone-stimulated bone resorption in cultured neonatal mouse calvaria
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Amylin is a secretory product of pancreatic beta-cells which shares major sequence homology with calcitonin gene-related peptide. In neonatal mouse calvaria maintained in organ culture for 72 h, amylin inhibited basal (i.e., unstimulated) resorption in medium concentrations above 2.5 x 10(-9) M. In addition, amylin (> or = 1.0 x 10(-7) M) in a calcitonin-like fashion transiently inhibited bone resorption induced by 1.0 x 10(-8) M PTH ("escape phenomenon"). Pretreatment of calvarial bones with amylin (1.0 x 10(-8) - 1.0 x 10(-6) M) for 72 h attenuated the subsequent response to 1.0 x 10(-8) M PTH. Changes in location and appearance of osteoclasts in amylin-treated bones, as visualized by light microscopy, suggest that amylin inhibits bone resorption by causing a loss of specialized contact zones to the mineralized matrix in resorbing osteoclasts, and in addition, by preventing retraction of osteoblasts from the mineralized surface which impedes attachment of osteoclasts thereon.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In an organ culture system of neonatal mouse calvariae, in which bone resorption was stimulated by 1,25(OH) 2 D 3 , amylin increased cAMP levels and reduced both basal and PTH-stimulated resorption (51,166).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [166]
Citations
Cites
Amyloid Deposits and Amyloidosis: The β-Fibrilloses(First of Two Parts)
Glenner, G. G. (1980) · New England Journal of Medicine · doi:10.1056/nejm198006053022305 · Cited by 1,790
Cooper, G. J., Willis, A. C., Clark, A., Turner, R. C., Sim, R. B., & Reid, K. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8628 · Cited by 1,299
Westermark, P., Wernstedt, C., Wilander, E., Hayden, D. W., O'Brien, T. D., & Johnson, K. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.11.3881 · Cited by 976
VAES, G. (1988) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198806000-00033 · Cited by 404
Lukinius, A., Wilander, E., Westermark, G. T., Engstr�m, U., & Westermark, P. (1989) · Diabetologia · doi:10.1007/bf00285291 · Cited by 371
ISLET AMYLOID FORMED FROM DIABETES-ASSOCIATED PEPTIDE MAY BE PATHOGENIC IN TYPE-2 DIABETES
Clark, A., Lewis, C. E., Willis, A. C., Cooper, G. J. S., Morris, J. F., Reid, K. B. M., & Turner, R. C. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90825-7 · Cited by 350
Opie, E. L. (1901) · Journal of Experimental Medicine · doi:10.1084/jem.5.5.527 · Cited by 305
Amylin secretion from the rat pancreas and its selective loss after streptozotocin treatment.
Ogawa, A., Harris, V, McCorkle, S. K., Unger, R. H., & Luskey, K. L. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114528 · Cited by 205
Hartter, E., Svoboda, T., Ludvik, B., Schuller, M., Lell, B., Kuenburg, E., Brunnbauer, M., Woloszczuk, W., & Prager, R. (1991) · Diabetologia · doi:10.1007/bf00404025 · Cited by 191
Research works printed but not linked: 4
- Datta, 1990, Amylin-amide competes with CGRP binding sites on osteoblast-like osteosarcoma cells, J. Bone Min. Res., 5, S229
- Ehrlich, 1961, Amyloidosis of the islets of Langerhans, Am. J. Pathol., 38, 49
- Klaushofer, 1989, Calcitonin enhances recruitment of osteoclasts in cultured mouse calvariae [Abstract], J. Bone Min. Res., 4, 368
- Koopmans, 1990, Pancreatic amylin induces hypocalcemia and antagonizes insulin action on carbohydrate metabolism in the rat, J. Bone Min. Res., 5, 193
Cited by
Type 2 diabetes and the skeleton: new insights into sweet bones
Shanbhogue, V. V., Mitchell, D. M., Rosen, C. J., & Bouxsein, M. L. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00283-1 · Cited by 237
The Impact of Diabetes and Diabetes Medications on Bone Health
Gilbert, M. P., & Pratley, R. E. (2015) · Endocrine Reviews · doi:10.1210/er.2012-1042 · Cited by 209
The Activity of Peptides of the Calcitonin Family in Bone
Naot, D., Musson, D. S., & Cornish, J. (2019) · Physiological Reviews · doi:10.1152/physrev.00066.2017 · Cited by 141
Diabetes pharmacotherapy and effects on the musculoskeletal system
Kalaitzoglou, E., Fowlkes, J. L., Popescu, I., & Thrailkill, K. M. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3100 · Cited by 100
Cornish, J., Callon, K. E., King, A. R., Cooper, G. J. S., & Reid, I. R. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.4.e694 · Cited by 102
Metadata
- Authors
- Pietschmann, P., Farsoudi, K. H., Hoffmann, O., Klaushofer, K., Hörandner, H., & Peterlik, M.
- Affiliations
- University of Vienna (AT)
- Hanusch Hospital (AT)
- Corresponding author
- Peterlik, M.
- ORCID
- Pietschmann, P.
- Venue
- Bone
- Publisher
- Elsevier BV
- Published
- 1993-03
- Volume
- 14
- Issue
- 2
- Pages
- 167-172
- ISSN
- 1873-2763 (ISSN-L)
- 8756-3282
- OpenAlex
- W2011791141
- Cited by
- 28
- References
- 25
- Citations by year
- 2020: 2 · 2019: 1 · 2018: 2 · 2016: 2 · 2015: 2 · 2013: 1
- FWCI
- 0.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Bone (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
- Keywords
- amylin, bone resorption, parathyroid hormone, osteoclasts, osteoblasts, calcitonin gene-related peptide, calvaria, mineralized matrix, neonatal mice
- MeSH terms
- Amyloid, Animals, Animals, Newborn, Bone Resorption, Organ Culture Techniques, Osteoclasts, Parathyroid Hormone, Stimulation, Chemical, Mice, Islet Amyloid Polypeptide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibitory effect of amylin on basal and parathyroid hormone-stimulated bone resorption in cultured neonatal mouse calvaria. https://app.cochat.ai/papers/10.1016/8756-3282(93)90244-5
- The paper
- Pietschmann, P., Farsoudi, K. H., Hoffmann, O., Klaushofer, K., Hörandner, H., & Peterlik, M. (1993). Inhibitory effect of amylin on basal and parathyroid hormone-stimulated bone resorption in cultured neonatal mouse calvaria. Bone. https://doi.org/10.1016/8756-3282(93)90244-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.